BioSig Technologies (BSGM) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS

BioSig Technologies (NASDAQ:BSGM) released its quarterly earnings results on Monday. The company reported ($0.33) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.30) by ($0.03), Fidelity Earnings reports.

BioSig Technologies stock opened at $6.46 on Wednesday. BioSig Technologies has a 1-year low of $3.50 and a 1-year high of $7.88.

In other news, CEO Kenneth L. Londoner acquired 18,700 shares of the firm’s stock in a transaction dated Tuesday, January 22nd. The stock was bought at an average price of $4.35 per share, with a total value of $81,345.00. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. 26.70% of the stock is currently owned by company insiders.

Several research firms have recently commented on BSGM. Zacks Investment Research cut shares of BioSig Technologies from a “hold” rating to a “sell” rating in a research note on Tuesday. Laidlaw set a $11.00 price objective on shares of BioSig Technologies and gave the company a “buy” rating in a research note on Wednesday, February 20th.

ILLEGAL ACTIVITY WARNING: “BioSig Technologies (BSGM) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS” was originally posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this article on another domain, it was copied illegally and republished in violation of international copyright & trademark laws. The correct version of this article can be read at https://www.thelincolnianonline.com/2019/04/17/biosig-technologies-bsgm-releases-quarterly-earnings-results-misses-expectations-by-0-03-eps.html.

About BioSig Technologies

BioSig Technologies, Inc, a development stage medical device company, engages in developing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. Its product is PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP System, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and catheter ablation procedures.

Featured Article: Do closed-end mutual funds pay dividends?

Earnings History for BioSig Technologies (NASDAQ:BSGM)

Receive News & Ratings for BioSig Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSig Technologies and related companies with MarketBeat.com's FREE daily email newsletter.